Latest Share Chat

DNL.L Share News (DNL)

DNL.L Information

There is currently no data for DNL

Diurnal Nets GBP500,000 From Broker Option Exercise (ALLISS)

Tue, 20th Mar 2018 18:28

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC on Tuesday said that it has received a letter of notice to exercise the broker option in respect of 263,157 shares, raising GBP500,000 in proceeds for the company.

The company expects to have 61.3 million shares in issue following the previously announced share placing, broker option and conversion of convertible loan.

Shares in Diurnal closed up 0.6% at price 200.20 pence on Tuesday.

More News

11 Jul 2016 06:45

Diurnal Hoping To Secure Infacort European Authorisation In Late 2017

30 Mar 2016 09:56

Diurnal Group Hit By IPO Cost, Sees First Product Approval At End 2017

23 Mar 2016 16:06

Earnings, Trading Statements Calendar - Week Ahead

29 Feb 2016 09:11

Diurnal Begins Dosing As Phase III Trial For Chronocort Drug Commences

12 Jan 2016 07:47

IP Group Says 2015 Was Likely Its Best Ever Financial Showing

24 Dec 2015 09:02

Latest Share Chat

DNL.L Share News (DNL)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Diurnal Nets GBP500,000 From Broker Option Exercise (ALLISS)

Diurnal Hoping To Secure Infacort European Authorisation In Late 2017

Diurnal Group Hit By IPO Cost, Sees First Product Approval At End 2017

Earnings, Trading Statements Calendar - Week Ahead

Diurnal Begins Dosing As Phase III Trial For Chronocort Drug Commences

IP Group Says 2015 Was Likely Its Best Ever Financial Showing

IP Group Portfolio Pharmaceutical Firm Diurnal Gains On AIM Debut (ALLIPO)

Login to your account

Quickpicks are a member only feature

Login to your account